- Advancing Gastroenterology and Hepatology through Creative Integration
- Abstract Submission and Registration are available via APDW 2018 website (www.apdw2018.org)
PG Course-PB (Korean) | ||
Nov. 15 (Thu) 09:00-10:30 |
Recent advances and problems in the management of pancreatobiliary disease | E1+2 (3F) |
Chairperson(s) | Sang-Heum Park (Cheonan), Sang-Woo Cha (Seoul) | |
09:00-09:20 | Pancreatobiliary maljunction: diagnostic criteria and proper management | Hyo Jung Kim (Seoul) |
09:20-09:40 | Optimal management of intrahepatic duct stones | Chang Hwan Park (Gwangju) |
09:40-10:00 | Recent advances in the management of advanced pancreatic neuroendocrine tumor | Chang Min Cho (Daegu) |
10:00-10:20 | Endoscopic management of biliary complication after liver transplantation | Jimin Han (Daegu) |
10:20-10:30 | Q&As |
PG Course-PB | ||
Nov. 15 (Thu) 11:00-12:30 |
Recent Progresses and optimal management of pancreatobiliary diseases | 103 (1F) |
Chairperson(s) | Yong-Tae Kim (Seoul), Jin Hong Kim (Suwon) | |
11:00-11:20 | Acute severe pancreatitis; Initial management, indications, timing and therapeutic modalities for drainage | D. Nageshwar Reddy (Hyderabad) |
11:20-11:40 | Pancreatic cystic neoplasm; Differential diagnosis, management & surveillance | Young Deok Cho (Seoul) |
11:40-12:00 | Bile duct stones and complications; Indication, timing and role of EUS, ERCP and cholecystectomy | Masayuki Kitano (Wakayama) |
12:00-12:20 | Cholangiocarcinoma; Diagnosis, staging and pre-operative tissue acquisition and stenting | Ichiro Yasuda (Toyama) |
12:20-12:30 | Q&As |
Symposium PB-01 | ||
Nov. 16 (Fri) 08:30-10:00 |
New insights in the biliary system | 104 (1F) |
Chairperson(s) | D. Nageshwar Reddy (Hyderabad), Ho Soon Choi (Seoul), Shutian Zhang (Beijing) | |
08:30-08:50 | Optimal evaluation of premalignant biliary lesions | Seon Mee Park (Cheongju) |
08:50-09:10 | Optimal approach to the indeterminate bile duct stricture | Hsiu-Po Wang (Taipei) |
09:10-09:30 | Updates on difficult biliary stones management | Chang-Il Kwon (Seongnam) |
09:30-09:50 | Best Endoscopic drainage of biliary system | Shutian Zhang (Beijing) |
09:50-10:00 | Q&As |
Free Paper (PB 1) (Korean) | ||
Nov. 16 (Fri) 08:30-10:00 |
KDDW Free Paper (PB 01) | E3 (3F) |
Chairperson(s) | Young Woo Choi (Daejeon), Kyu Taek Lee (Seoul) | |
08:30-08:40 | Comparison of therapeutic efficacy and safety between standard-dose FOLFIRINOX and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer: a retrospective study | Huapyong Kang (Seoul) |
08:40-08:50 | Korean experiences with liposomal irinotecan for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy. | Juyeon Oh (Goyang) |
08:50-09:00 | Comparison of FOLFIRINOX and Gemcitabine with Nab-paclitaxel in Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer Registry (K-PAC) | Jong-Chan Lee (Seongnam) |
09:00-09:10 | Surveillance versus surgery for incidental, asymptomatic, small solid pseudopapillary neoplasm (SPN) of the pancreas | Joune Seup Lee (Seoul) |
09:10-09:20 | Efficacy of endobiliary radiofrequency ablation for malignant distal biliary obstruction: A propensity score matched multicenter study | Eui Joo Kim (Incheon) |
Chairperson(s) | Seokho Dong (Seoul), Don Haeng Lee (Incheon) | |
09:20-09:30 | The importance of elevated serum viscosity in pancreaticobiliary cancer patients | Hwang Seonyeong (Seoul) |
09:30-09:40 | Prognostic impact of minimal Pelvic Fluid in pancreatic cancer stage III | Young-Hwa Kim (Incheon) |
09:40-09:50 | Chromogranin A as a prognostic marker in pancreatic adenocarcinoma | Jung Hyun Jo (Seoul) |
09:50-10:00 | complementary role of Serum DUPAN-2 for screening of Carbohydrate Antigen 19-9 in patients with pancreatico-biliary malignancy | Jae Woo Kim (Wonju) |
Free Paper (PB 2) (Korean & English) | ||
Nov. 16 (Fri) 10:30-12:00 |
KDDW Free Paper (PB 02) | E3 (3F) |
Chairperson(s) | Tae Nyeun Kim (Daegu), Young Deok Cho (Seoul) | |
10:30-10:40 | Differences in clinical features and outcomes of hypertriglyceridemia induced acute pancreatitis from the prospective acute pancreatitis registry of 558 patients. | So Jeong Kim (Incheon) |
10:40-10:50 | Acute pancreatitis in pregnant women. Features of diagnosis and treatment tactics | Nurmurod Ne'mat O'g'li Esanov (Tashkent) |
10:50-11:00 | Risk factors and outcomes of deep vein thrombosis in patients with necrotizing pancreatitis | Du-Jiang Yang (Chengdu) |
Chairperson(s) | Hong Sik Lee (Seoul), Byung Moo Yoo (Suwon) | |
11:00-11:10 | Comparison between groove pancreatitis and groove pancreatitis with extensive chronic pancreatitis | Jae Hyuck Jun (Daejeon) |
11:10-11:20 | Comparison of clinical outcomes between plastic stent and lumen-apposing metal stent for endoscopic ultrasound-guided drainage of peripancreatic fluid collections: A retrospective single centre experience | Chang Min Cho (Daegu) |
11:20-11:30 | Efficacy of intramuscular diclofenac in the prevention of post-ERCP pancreatitis: A prospective, randomized, placebo-controlled study | Byung Sam Park (Daegu) |
Symposium PB-02 | ||
Nov. 16 (Fri) 14:00-15:30 |
Cutting edge of pancreatic diseases | 104 (1F) |
Chairperson(s) | Chengwei Tang (Chengdu), Hsiu-Po Wang (Taipei) | |
14:00-14:20 | Updates on the management of severe acute pancreatitis | Chengwei Tang (Chengdu) |
14:20-14:40 | Pancreatic enzyme replacement therapy in chronic pancreatitis | Hong Sik Lee (Seoul) |
14:40-15:00 | Updates on Ig G4 related diseases | Kazuichi Okazaki (Hirakata) |
15:00-15:20 | Current status of pancreatic cystic neoplasm management | Aiming Yang (Beijing) |
15:20-15:30 | Q&As |
Free Paper (PB 3) (Korean) | ||
Nov. 16 (Fri) 14:00-15:30 |
KDDW Free Paper (PB 03) | E3 (3F) |
Chairperson(s) | Jaeseon Kim (Seoul), Seon Mee Park (Cheongju) | |
14:00-14:10 | Acalculous cholecystitis in burn intensive care unit patients: Incidence and predisposing factors | Hoongoo Lee (Hwaseong) |
14:10-14:20 | Clinical characteristics of colonic adenoma according to characteristics of gallstones | Jaehyun Tae (Seoul) |
14:20-14:30 | Chronological changes of epidemiologic characteristics of gallstone over last 20years in Korean single large volume center | Jiyong Zhao (Seoul) |
14:30-14:40 | Incidence and risk factors for gallstone formation after surgical and endoscopic therapy | Soyeong Kim (Daegu) |
Chairperson(s) | Jin Lee (Hwasung), Jong Hyeok Kim (Anyang) | |
14:40-14:50 | Incidence of cholelithiasis in patients with inflammatory bowel disease | Sooyeong Kwak (Daegu) |
14:50-15:00 | Biliary tuberculosis impersonating as cholangiocarcinoma: Single- center experiences | Jae Hyuck Jun (Daejeon) |
15:00-15:10 | Outcomes of endoscopic papillary large balloon dilation for bile duct stones: Before and after international consensus guideline | Dae Jung Kim (Suwon) |
Symposium PB-03 | ||
Nov. 16 (Fri) 16:00-17:30 |
Recent advances in intra- and extrahepatic cholangiocarcinoma: promising or practice changing? | 203 (2F) |
Chairperson(s) | Ho Soon Choi (Seoul), Ji Kon Ryu (Seoul), Dong Sup Yoon (Seoul) | |
17:20-17:30 | Dong Hee Koh (Hwaseong) |
|
16:00-16:20 | Pathogenesis and molecular characterization: from genetics to signaling pathways | Young Nyun Park (Seoul) |
16:20-16:40 | Pathologic classification: new concepts | Kyoungbun Lee (Seoul) |
16:40-17:00 | Endoscopic management: from ERCP to EUS | Masayuki Kitano (Wakayama) |
17:00-17:20 | Selection of patients for curative resection and role of surgery: from resection to transplantation | Masayuki Ohtsuka (Chiba) |
Free Paper (PB 4) (Korean) | ||
Nov. 16 (Fri) 16:00-17:30 |
KDDW Free Paper (PB 04) | E3 (3F) |
Chairperson(s) | Seong Woo Nam (Seoul), Young Koog Cheon (Seoul) | |
16:00-16:10 | Antitumor effects of flavokawain B on cholangiocarcinoma | Young Hoon Choi (Seoul) |
16:10-16:20 | Carbohydrate antigen 19-9 as a prognostic marker of intrahepatic cholangiocarcinoma after surgical resection | Gunn Huh (Seoul) |
16:20-16:30 | Clinical relevance of BilIN in surgical margin of perihilar cholangiocarcinoma | Soong Goo Jung (Seoul) |
Chairperson(s) | Young Soo Moon (Busan), Se-Joon Lee (Yongin) | |
16:30-16:40 | Efficacy and safety of simultaneous side-by-side bilateral placement of braided-type metal stents using 6F-introducer for unresectable malignant hilar bile duct obstruction: A retrospective feasibility study | Doo Hyun Ko (Inchon) |
16:40-16:50 | Comparison of preoperative CT scan, EUS Findings, and Histopathologic Findings of Gallbladder Polyps Larger than 1 cm in Size | Jae Kook Yang (Cheonan) |
16:50-17:00 | Long-term outcomes of endoscopic papillectomy after an insulated plastic pancreatic stent placement | Sun Ung Youn (Suwon) |
Symposium PB-04 | ||
Nov. 17 (Sat) 08:30-10:00 |
Gallbladder disease: unsolved problems revisited | 203 (2F) |
Chairperson(s) | Jong Kyun Lee (Seoul), Joo Ha Hwang (Stanford) | |
08:30-08:50 | What are the true risk factors and precursors to gallbladder cancer? | Joo Ha Hwang (Stanford) |
08:50-09:10 | Differential diagnosis between gallbladder cancer and benign gallbladder disease | Mi-Suk Park (Seoul) |
09:10-09:30 | Endoscopic gallbladder drainage compared with percutaneous drainage: advantages and limitations | Seong-Hun Kim (Jeonju) |
09:30-09:50 | Surgical strategies for acute cholecystitis in the era of minimal invasive approach: when and how? | Keun Soo Ahn (Daegu) |
09:50-10:00 | Q&As |
Symposium PB-05 | ||
Nov. 18 (Sun) 13:30-15:00 |
Recent advances in malignant pancreatobiliary diseases | 104 (1F) |
Chairperson(s) | Dadang Makmun (Jakarta), Myung-Hwan Kim (Seoul) | |
13:30-13:50 | How to find out the early detection of pancreatobiliry cancer | Khek Yu Ho (Singapore) |
13:50-14:10 | Optimal endoscopic management of Borderline non-resectable pancreatic cancer | Eun Taek Park (Busan) |
14:10-14:30 | Optimal management of borderline resectable pancreatic cancer | Hidenori Takahashi (Osaka) |
14:30-14:50 | Current Status and Future Directions in Chemotherapy for pancreatiBiliary Tract Cancer | Seung Woo Park (Seoul) |
14:50-15:00 | Q&As |